35.53
price up icon9.19%   2.99
after-market アフターアワーズ: 35.53
loading
前日終値:
$32.54
開ける:
$32.51
24時間の取引高:
290.02K
Relative Volume:
1.88
時価総額:
$445.08M
収益:
-
当期純損益:
$-31.48M
株価収益率:
-34.16
EPS:
-1.04
ネットキャッシュフロー:
$-28.71M
1週間 パフォーマンス:
+16.84%
1か月 パフォーマンス:
+27.48%
6か月 パフォーマンス:
+206.29%
1年 パフォーマンス:
+133.14%
1日の値動き範囲:
Value
$31.90
$35.62
1週間の範囲:
Value
$29.80
$35.62
52週間の値動き範囲:
Value
$4.90
$35.62

Forte Biosciences Inc Stock (FBRX) Company Profile

Name
名前
Forte Biosciences Inc
Name
セクター
Healthcare (1114)
Name
電話
(310) 618-6994
Name
住所
3060 PEGASUS PARK DRIVE, DALLAS, CA
Name
職員
16
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
FBRX's Discussions on Twitter

FBRX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
FBRX
Forte Biosciences Inc
35.53 407.63M 0 -31.48M -28.71M -1.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.17 120.98B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
771.25 80.15B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
864.42 51.56B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
354.75 47.74B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ONC
Beone Medicines Ltd Adr
336.16 37.38B 4.98B 69.59M 525.67M 0.5197

Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-25 開始されました Evercore ISI Outperform
2025-08-18 開始されました Guggenheim Buy
2025-01-21 開始されました TD Cowen Buy
2024-04-08 アップグレード Ladenburg Thalmann Neutral → Buy
2021-09-20 アップグレード Chardan Capital Markets Sell → Buy
2021-09-03 ダウングレード B. Riley Securities Buy → Neutral
2021-09-03 ダウングレード Chardan Capital Markets Buy → Sell
2021-09-03 ダウングレード Ladenburg Thalmann Buy → Neutral
2021-09-03 ダウングレード Truist Buy → Hold
2021-05-14 開始されました B. Riley Securities Buy
2021-03-26 開始されました Citigroup Buy
2020-08-28 アップグレード Chardan Capital Markets Neutral → Buy
2020-08-25 開始されました Truist Buy
すべてを表示

Forte Biosciences Inc (FBRX) 最新ニュース

pulisher
Jan 24, 2026

US Market Recap: What is the earnings history of Jupiter Neurosciences Inc2025 Stock Rankings & Accurate Entry and Exit Point Alerts - baoquankhu1.vn

Jan 24, 2026
pulisher
Jan 22, 2026

Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat

Jan 22, 2026
pulisher
Jan 21, 2026

CD122’s double whammy makes for intriguing target - BioWorld MedTech

Jan 21, 2026
pulisher
Jan 19, 2026

Is Forte Biosciences Inc. stock oversold or undervaluedJuly 2025 Sector Moves & Real-Time Volume Triggers - bollywoodhelpline.com

Jan 19, 2026
pulisher
Jan 18, 2026

Is Forte Biosciences Inc a top pick in the sectorWeekly Trade Review & Expert Verified Movement Alerts - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 18, 2026

Support Test: How does INVE compare to its peersQuarterly Portfolio Review & Daily Growth Stock Tips - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 18, 2026

Layoff Watch: Is ERAS stock undervalued right nowMarket Performance Summary & Safe Entry Momentum Stock Tips - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 15, 2026

Value Recap: Does Forte Biosciences Inc have pricing powerPortfolio Gains Report & Daily Growth Stock Tips - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 14, 2026

Trade Recap: Is Forte Biosciences Inc. stock a hidden gemWeekly Gains Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 14, 2026

Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Jan 14, 2026
pulisher
Jan 13, 2026

Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Up 267.7% in December - MarketBeat

Jan 13, 2026
pulisher
Jan 12, 2026

Delaware court rules in D&O dispute - businessinsurance.com

Jan 12, 2026
pulisher
Jan 12, 2026

Delaware court expands D&O insurer liability through meaningful linkage ruling - Insurance Business

Jan 12, 2026
pulisher
Jan 10, 2026

A activityJuly 2025 Analyst Calls & Weekly Top Gainers Trade List - ulpravda.ru

Jan 10, 2026
pulisher
Jan 10, 2026

Will Forte Biosciences Inc. stock outperform international peersLayoff News & High Return Stock Watch Alerts - Улправда

Jan 10, 2026
pulisher
Jan 09, 2026

Biopharma Co. Secures D&O Coverage For Shareholder Suit - Law360

Jan 09, 2026
pulisher
Jan 09, 2026

Why Forte Biosciences Inc. stock is rated strong buyWeekly Investment Summary & Expert Curated Trade Ideas - Улправда

Jan 09, 2026
pulisher
Jan 09, 2026

Biotech Firm Scores Win in D&O Insurance Coverage Dispute - Bloomberg Law News

Jan 09, 2026
pulisher
Jan 09, 2026

Will Forte Biosciences Inc. stock reach all time highs in 2025CPI Data & Expert Curated Trade Setups - Улправда

Jan 09, 2026
pulisher
Jan 09, 2026

How supply shortages influence HCI stockJuly 2025 Review & Community Driven Trade Alerts - Улправда

Jan 09, 2026
pulisher
Jan 08, 2026

What margin trends mean for VNET Group Inc. Depositary Receipt stockTrade Risk Report & Long-Term Safe Investment Ideas - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

What valuation multiples suggest for HAYW stockWeekly Risk Summary & Consistent Growth Equity Picks - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

ulpravda ru > 2026> What insider trading reveals about COLL stockChart Signals & Low Drawdown Momentum Ideas - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Will Quad Graphics Inc. stock return to pre crisis levels2025 Key Highlights & Expert Approved Trade Ideas - ulpravda.ru

Jan 08, 2026
pulisher
Jan 08, 2026

Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - MarketBeat

Jan 08, 2026
pulisher
Jan 06, 2026

(FBRX) Movement as an Input in Quant Signal Sets - Stock Traders Daily

Jan 06, 2026
pulisher
Jan 06, 2026

Will Avax Apparels and Ornaments Limited Bounce From 52 Week LowPortfolio Risk Assessment & Interactive Learning for Better Returns - earlytimes.in

Jan 06, 2026
pulisher
Jan 05, 2026

Will Sahasra Electronic Solutions Limited Recover After Recent DeclineSupport and Resistance Levels & Access Free Risk Analysis Before You Invest - earlytimes.in

Jan 05, 2026
pulisher
Jan 05, 2026

What drives Forte Biosciences Inc stock priceMean Reversion Trades & Receive Monthly Expert Trading Blueprints - earlytimes.in

Jan 05, 2026
pulisher
Jan 04, 2026

TD Cowen Initiates Coverage of Forte Biosciences (FBRX) with Buy Recommendation - MSN

Jan 04, 2026
pulisher
Jan 04, 2026

Chief Financial Officer of Forte Biosciences Picks Up 30% More Stock - Yahoo Finance

Jan 04, 2026
pulisher
Jan 03, 2026

Institutional investors may adopt severe steps after Forte Biosciences, Inc.'s (NASDAQ:FBRX) latest 15% drop adds to a year losses - simplywall.st

Jan 03, 2026
pulisher
Jan 02, 2026

Insider Buying: Antony Riley Acquires Shares of Forte Biosciences Inc (FBRX) - GuruFocus

Jan 02, 2026
pulisher
Jan 01, 2026

Trading Bots Trigger Alerts on Shri Venkatesh Refineries Limited ActivityHigh Frequency Trading Trends & Fast Profit Trading Ideas - bollywoodhelpline.com

Jan 01, 2026
pulisher
Jan 01, 2026

Indo Tech Transformers Limited (INDOTECH) Stock RalliesStock Liquidity Analysis & Discover Stocks Experts Are Watching - bollywoodhelpline.com

Jan 01, 2026
pulisher
Jan 01, 2026

Dr. Lal PathLabs Limited (LALPATHLAB) Expands into New MarketRisk-Reward Ratio Analysis & Fast Profit Capital Growth - bollywoodhelpline.com

Jan 01, 2026
pulisher
Jan 01, 2026

Forte Biosciences Inc. (FBRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jan 01, 2026
pulisher
Dec 28, 2025

Shorts Report: Will Forte Biosciences Inc stock return to pre crisis levelsJuly 2025 Update & Consistent Profit Trade Alerts - moha.gov.vn

Dec 28, 2025
pulisher
Dec 26, 2025

(FBRX) Volatility Zones as Tactical Triggers - Stock Traders Daily

Dec 26, 2025
pulisher
Dec 25, 2025

Gaining experience for doing equity researchDividend Yield Trends & Free Fastest Return On Investment - bollywoodhelpline.com

Dec 25, 2025
pulisher
Dec 25, 2025

Rate Hike: Is Forte Biosciences Inc stock dividend yield sustainable2025 Pullback Review & Weekly Watchlist of Top Performers - moha.gov.vn

Dec 25, 2025
pulisher
Dec 25, 2025

Stock Traders Buy Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - MarketBeat

Dec 25, 2025
pulisher
Dec 22, 2025

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - Bluefield Daily Telegraph

Dec 22, 2025
pulisher
Dec 22, 2025

New Forte Biosciences hire receives options for 75,000 shares - Stock Titan

Dec 22, 2025
pulisher
Dec 21, 2025

Gainers Report: Can Cytosorbents Corporation stock deliver sustainable ROEJuly 2025 Patterns & Fast Exit and Entry Trade Guides - moha.gov.vn

Dec 21, 2025
pulisher
Dec 21, 2025

Why analysts upgrade Forte Biosciences Inc. stock2025 Top Gainers & Expert Curated Trade Ideas - Улправда

Dec 21, 2025
pulisher
Dec 20, 2025

Ester Industries Limited Recovers — But Is It SustainableGap Fill Strategies & Low Risk Capital Growth - Bollywood Helpline

Dec 20, 2025
pulisher
Dec 20, 2025

Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Dec 20, 2025
pulisher
Dec 20, 2025

Forte Biosciences, Inc. (NASDAQ:FBRX) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Dec 20, 2025
pulisher
Dec 20, 2025

Dow Update: Why Dune Acquisition Corporation Equity Warrant stock remains on buy listsPortfolio Profit Report & Low Risk Entry Point Guides - Улправда

Dec 20, 2025
pulisher
Dec 19, 2025

Forte Biosciences initiated with an Outperform at Evercore ISI - MSN

Dec 19, 2025

Forte Biosciences Inc (FBRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Forte Biosciences Inc (FBRX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Riley Antony A
CHIEF FINANCIAL OFFICER
Jan 01 '26
Option Exercise
0.00
375
0
41,895
Riley Antony A
CHIEF FINANCIAL OFFICER
Dec 30 '25
Buy
26.33
9,680
254,833
41,520
Riley Antony A
CHIEF FINANCIAL OFFICER
Oct 01 '25
Option Exercise
0.00
375
0
31,974
Wagner Paul A.
SEE REMARKS
Oct 01 '25
Option Exercise
0.00
1,250
0
82,190
Riley Antony A
CHIEF FINANCIAL OFFICER
Jul 01 '25
Option Exercise
0.00
375
0
31,733
Wagner Paul A.
SEE REMARKS
Jul 01 '25
Option Exercise
0.00
1,250
0
81,038
Riley Antony A
CHIEF FINANCIAL OFFICER
Apr 01 '25
Option Exercise
0.00
375
0
31,372
Wagner Paul A.
SEE REMARKS
Apr 01 '25
Option Exercise
0.00
1,250
0
79,806
$99.82
price up icon 2.09%
$103.47
price up icon 0.87%
$34.40
price up icon 2.78%
$119.34
price up icon 1.14%
$162.64
price up icon 1.83%
biotechnology ONC
$336.16
price down icon 0.48%
大文字化:     |  ボリューム (24 時間):